By vgreene, 2 March, 2020 Counsel pts on how to safely d/c and restart PrEP both when starting PrEP and when d/c’ing PrEP as HIV infxn protection wanes 7-10 days after ceasing daily PrEP use
By vgreene, 2 March, 2020 Perform HCV testing as part of baseline lab eval; consider annual retesting for those w/ ongoing risk of HCV exposure
By vgreene, 2 March, 2020 F/U q3mo for HIV test [IA],5 med adherence counseling, risk redux support [IIIA], ADR & STI assessment; test (incl oral + rectal) for bacterial STIs (syphilis, gonorrhea, chlamydia) q3mo if high risk for recurrent STI (recent STI or multiple partners)
By vgreene, 2 March, 2020 PrEP may be indicated if: neg HIV test, no s/sx of acute HIV infxn [IA], normal renal fxn;1no contraindicated meds; documented HBV/vaccine status2
By vgreene, 2 March, 2020 Risk Criteria: HIV+ partner, recent (w/in 6mo) bacterial STI (syphilis, gonorrhea, or chlamydia), high # of partners, inconsistent/no condom use, commercial sex work, in high-prevalence area, HIV+ injecting partner, sharing injxn equip
By vgreene, 2 March, 2020 Counsel pts on how to safely d/c and restart PrEP both when starting PrEP and when d/c’ing PrEP as HIV infxn protection wanes 7-10 days after ceasing daily PrEP use